Changing figures of antimicrobial susceptibility and serovar distribution in Neisseria gonorrhoeae isolated in Greece

Sexually Transmitted Diseases

Volumn 37, Issue 2, 2010, Pages 115-120

  Tzelepi, Eva ^a   Avgerinou, Helen ^b   Flemetakis, Alexandros ^b   Siatravani, Eirini ^a,b   Stathi, Maria ^a   Daniilidou, Maria ^c   Miriagou, Vivi ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b Hospital for Venereal and Skin Diseases 'A Syngros'   (Greece)

^c Hospital for Skin and Venereal Diseases   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; PENICILLIN G; SPECTINOMYCIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; GREECE; HEALTH SURVEY; NEISSERIA GONORRHOEAE; NONHUMAN; PHENOTYPE; SEROTYPING;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GONORRHEA; GREECE; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PHENOTYPE; SEROTYPING;

EID: 77649145348     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181bcd0b8     Document Type: Article

References (20)

1. O?Rourke M, Stevens E. Genetic structure of Neisseria gonor-rhoeae populations: A non-clonal pathogen. J Gen Microbiol 1993; 139:2603-2611.
2. Ison CA, Dillon JA, Tapsall JW. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Hae-mophilus ducreyi. Lancet 1998; 351(suppl III):8-11.
3. Tapsall J. Current concepts in the management of gonorrhoea. Expert Opin Pharmacother 2002; 3:147-157.
4. Gill MJ, Ross JD. Role of typing in genitourinary medicine. Sex Transm Infect 1999; 75:211-213.
5. Stathi M, Flemetakis A, Miriagou V, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece. Data for the years 1994-2004. J Antimicrob Chemother 2006; 57:775-779.
6. Tzelepi E, Daniilidou M, Miriagou V, et al. Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece. J Antimicrob Che-mother 2008; 62:637-639
7. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Informational Supplement M100-S15. Wayne, PA: CLSI, 2005.
8. Ison CA, Papin J, Roope NS, et al. The dominance of a multire-sistant strain of Neisseria gonorrhoeae among prostitutes and STD patients in the Gambia. Genitourin Med 1992; 68:356-360.
9. Gascoyne-Binzi DM, Hawkey PM, Heritage J. The distribution of the Tet M determinant in tetracycline-resistant Neisseria gonor-rhoeae. J Antimicrob Chemother 1994; 33:1011-1016.
10. Portnoy DA, Moseley SL, Falkow S. Characterization of plas-mids and plasmid-associated determinants of Yersinia enteroco-litica pathogenesis. Infect Immun 1981; 31:775-782.
11. Bygdeman S, Danielson D, Sandstrom E. Gonococcal W sero-groups in Scandinavia. A study with polyclonal and monoclonal antibodies. Acta Pathol Mucrobiol Immunol Scand 1983; 31:775-782.
12. Xia M, Whittington WL, Holmes KK, et al. Pulsed-field gel electrophoresis for genomic analysis of Neisseria gonorrhoeae. J Infect Dis 1995; 171:455-458.
13. Tapsall J. Antimicrobial Resistance in Neisseria gonorrhoeae. Geneva, Switzerland: World Health Organization, 2001.
14. Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis 2007; 44:S84-S101.
15. Bala M, Jain RK, Ray K. Antimicrobial susceptibility profile of resistance phenotypes of Neisseria gonorrhoeae in India. Sex Transm Dis 2008; 35:588-591.
16. Dan M. The use of fluoroquinolones in gonorrhoea: The increasing problem of resistance. Expert Opin Pharmacother 2004; 5:829-854.
17. Barry PM, Klausner J. The use of cephalosporins for gonorrhea: The impending problem of resistance. Expert Opin Pharmacother 2009; 10:1-23.
18. Lindberg R, Fredlund H, Nicholas E, et al. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b and ponA. Antimicrob Agents Chemother 2007; 51:2117-2122.
19. Mavroidi A, Tzouvelekis LS, Kyriakis KP, et al. Multidrug-resistant strains of Neisseria gonorrhoeae in Greece. Antimicrob Agents Chemother 2001; 45:2651-2654.
20. Tapsall J. Multidrug-resistant Neisseria gonorrhoeae. Can Med Assoc J (CMAJ) 2009; 180:268-269.